[{"NetIncomeLossConverted_4_FY_USD":6193700000.0,"StockholdersEquityConverted_0_FY_USD":5825200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":907634000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":6499600000.0,"EarningsPerShareDiluted_4_FY_USD":6.79,"StockholdersEquity_0_FY_USD":5641600000.0,"Assets_0_FY_USD":46633100000.0,"CommonStockSharesConverted_0_FY_shares":957077.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":3.07,"RevenuesConverted_4_FY_USD":24539800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":912505000.0,"EarningsPerShareBasic_4_FY_USD":6.82,"Ticker":"LLY","CIK":"59478","name":"ELI LILLY & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20210217"}]